Tamarack Capital Management’s Oxford Immunotec Global OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
– Sell
-375,000
Closed -$5.06M – 27
2015
Q3
$5.06M Sell
375,000
-129,668
-26% -$1.76M 0.6% 26
2015
Q2
$6.99M Buy
504,668
+52,535
+12% +$711K 0.8% 29
2015
Q1
$6.37M Buy
+452,133
New +$6.15M 0.84% 29
2014
Q2
– Sell
-167,625
Closed -$3.36M – 32
2014
Q1
$3.36M Sell
167,625
-107,375
-39% -$2.32M 0.84% 23
2013
Q4
$5.33M Buy
+275,000
New +$4.86M 1.26% 22

Other funds holding OXFD

Tamarack Capital Management's OXFD Position: Q4 2015 in Review

Tamarack Capital Management sold out of Oxford Immunotec Global (OXFD) in Q4 2015, closing a stake of 375,000 shares — an estimated $5.06M sold.

Tamarack Capital Management first reported a position in OXFD in Q4 2013 and held it in 5 quarters. The position peaked at $6.99M in Q2 2015. 65 funds tracked by Wall St. Rank hold OXFD as of Q4 2015.

  • Tamarack Capital Management reported no remaining Oxford Immunotec Global position as of Q4 2015 after selling out during the quarter.
  • Tamarack Capital Management sold 375,000 Oxford Immunotec Global shares in Q4 2015, an estimated $5.06M.
  • Tamarack Capital Management first reported a position in Oxford Immunotec Global in Q4 2013 and held it in 5 quarters.
  • Tamarack Capital Management's Oxford Immunotec Global position peaked at $6.99M in Q2 2015.
  • 65 funds tracked by Wall St. Rank held Oxford Immunotec Global as of Q4 2015.

Based on Tamarack Capital Management's 13F filing for Q4 2015.